Impaired cell-mediated immunity in patients with kala-azar
Hepner Levy, L.; Mendes, E.
Allergologia et Immunopathologia 9(2): 109-112
1981
ISSN/ISBN: 0301-0546 PMID: 7293874 Document Number: 175457
Delayed hypersensitivity by intracutaneous tests with leishmanin, tuberculin, trichophytin, oidiomycin, as well as sensitization with DNCB were assessed in ten patients with kala-azar. There was a significant depression of delayed hypersensitivity to leishmanin (Montenegro reaction) during the active phase of the disease. The response to ubiquitous microbial antigens and DNCB were also depressed as compared to controls.
Document emailed within 1 workday
Related Documents
Mayrink, W.; Magalhàes, P.A.; Batista, S.M.; da Costa, C.A. 1971: Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment Revista do Instituto de Medicina Tropical de Sao Paulo 13(4): 268-271Sultana, A.; Zakaria, S.M.; Bhuiyan, S.I.; Habib, A.; Dey, S.K.; Rahman, M.; Basher, A. 2012: Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh Mymensingh Medical Journal: Mmj 21(3): 529-532
Sharma, V.K.; Jha, T.K. 1986: Recurrence of Kala-azar in a Case of Post Kala-azar Dermal Leishmaniasis Indian Journal of Dermatology Venereology and Leprology 52(1): 46-47
Arvanitakis, C.; Knouss, R.F. 1973: Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis JAMA 225(12): 1492-1495
Lederman, M.M.; Ratnoff, O.D.; Schacter, B.; Shoger, T. 1985: Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines Journal of Laboratory and Clinical Medicine 106(2): 197-204
Kobayashi, K.; Allred, C.; Yoshida, T. 1985: Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice Journal of Immunology 135(5): 2996-3003
Sacks, D.L.; Lal, S.L.; Shrivastava, S.N.; Blackwell, J.; Neva, F.A. 1987: An analysis of T cell responsiveness in Indian kala-azar Journal of Immunology 138(3): 908-913
Mondal, D.; Hasnain, M.G.; Hossain, M.S.; Ghosh, D.; Ghosh, P.; Hossain, H.; Baker, J.; Nath, R.; Haque, R.; Matlashewski, G.; Hamano, S. 2016: Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol Bmj Open 6(5): E010050
Katsura, Y. 1980: Mechanisms of the expression of cell-mediated immunity: cells and mediators involved in cell-mediated immunity Rinsho Byori. Japanese Journal of Clinical Pathology 28(11): 1068-1074
Marwaha, N.; Sarode, R.; Gupta, R.K.; Garewal, G.; Dash, S. 1991: Clinico-hematological characteristics in patients with kala azar. a study from north-west India Tropical and Geographical Medicine 43(4): 357-362
Ting, C.C.; Bonnard, G.D. 1976: Cell-mediated immunity to friend virus-induced leukemia. IV. in vitro generation of primary and secondary cell-mediated cytotoxic responses Journal of Immunology 116(5): 1419-1425
Bonavida, B. 1974: Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis Journal of Immunology 112(4): 1308-1321
Hiserodt, J.C.; Bonavida, B. 1981: Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes Journal of Immunology 126(1): 256-262
Singh S; Kumar, J.; Singh, R.; Dwivedi, S.N. 2000: Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 203-208
Hasatomi, K.; Yasunaga, H.; Isomura, T.; Fukunaga, S.; Hirano, A.; Kosuga, K.; Oishi, K. 1992: The changes of the cell-mediated immunity in patients with administration of recombinant erythropoietin Nihon Geka Gakkai Zasshi 93(5): 518-522
Rao, R.S.; Fakih, A.R.; Nair, C.N.; Gangal, S.G.; Naik, S.L. 1984: Evaluation of cell-mediated immunity in oral cancer patients Indian Journal of Cancer 21(5-6): 141-145
Bjorvatn, B. 1990: Kala-azar Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(27): 3476-3477
Fuchs, R.; Mey, U. 1977: Studies on cell-mediated immunity in patients with chronic lymphatic leukemia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(19): 495-499
Sato, H.; Sasaki, M.; Kumano, N.; Oizumi, K.; Motomiya, M.; Konno, K. 1986: Serum factors and cell-mediated immunity in patients with pulmonary tuberculosis Kekkaku: 61(5): 293-297
Elias, L.L.; Elias, E.G. 1975: In vitro study of cell-mediated immunity of patients with colorectal carcinoma Surgical Forum 26: 131-132